SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 61 filers reported holding SYNERON MEDICAL LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $803,000 | +3.6% | 73,425 | 0.0% | 0.00% | – |
| Q1 2017 | $775,000 | +28.7% | 73,425 | +2.6% | 0.00% | – |
| Q4 2016 | $602,000 | +83.0% | 71,591 | +55.5% | 0.00% | – |
| Q3 2016 | $329,000 | -7.1% | 46,038 | 0.0% | 0.00% | – |
| Q2 2016 | $354,000 | +124.1% | 46,038 | +112.1% | 0.00% | – |
| Q1 2016 | $158,000 | -5.4% | 21,701 | 0.0% | 0.00% | – |
| Q4 2015 | $167,000 | +7.7% | 21,701 | 0.0% | 0.00% | – |
| Q3 2015 | $155,000 | -32.9% | 21,701 | 0.0% | 0.00% | – |
| Q2 2015 | $231,000 | +59.3% | 21,701 | +86.1% | 0.00% | – |
| Q1 2015 | $145,000 | +33.0% | 11,662 | 0.0% | 0.00% | – |
| Q4 2014 | $109,000 | -6.8% | 11,662 | 0.0% | 0.00% | – |
| Q3 2014 | $117,000 | -30.4% | 11,662 | -28.4% | 0.00% | – |
| Q2 2014 | $168,000 | -16.4% | 16,298 | +1.4% | 0.00% | – |
| Q1 2014 | $201,000 | – | 16,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 3,684,151 | $36,915,000 | 3.46% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $30,060,000 | 2.29% |
| HOURGLASS CAPITAL, LLC | 954,048 | $9,560,000 | 1.27% |
| Broadfin Capital, LLC | 1,005,221 | $10,072,000 | 1.06% |
| DAFNA Capital Management LLC | 90,947 | $911,000 | 0.92% |
| SOPHROSYNE CAPITAL LLC | 71,300 | $713,000 | 0.84% |
| PERRITT CAPITAL MANAGEMENT INC | 400,000 | $4,008,000 | 0.74% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 501,663 | $5,027,000 | 0.70% |
| Iguana Healthcare Management, LLC | 120,000 | $1,202,000 | 0.64% |
| Baupost Group | 2,994,610 | $30,006,000 | 0.52% |